Personal Control Over Decisions to Participate in Research by Persons With Histories of Both Substance Use Disorders and Criminal Justice Supervision

Abstract

Individuals must feel free to exert personal control over decisions regarding research participation. We present an examination of participants’ perceived personal control over, as well as reported pressures and threats from others, influencing their decision to join a study assessing the effectiveness of extended-release naltrexone in preventing opioid dependence relapse. Most participants endorsed a strong sense of control over the decision; few reported pressures or threats. Although few in number, participants’ brief narrative descriptions of the pressures and threats are illuminating and provide context for their perceptions of personal control. Based on this work, we propose a useful set of tools to help ascertain participants’ sense of personal control in joining research.

Keywords

decision making perceived personal control research ethics substance use disorder criminal justice supervision

Get full access to this article

View all access options for this article.

References

Additional Protections Pertaining to Biomedical and Behavioral Research Involving Prisoners as Subjects. C.F.R. 45, §§ 46-46.301-46.306 (2017)

Allen

A. A.

Chen

D. T.

Bonnie

R. J.

T. M.

Suratt

C. E.

Lee

J. D.

. . . O’Brien

C. P.

(2017). Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervision. Journal of Substance Abuse Treatment, 81, 66-72.

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.

Appelbaum

P. S.

Lidz

C. W.

Klitzman

(2009a). Voluntariness of consent to research: A conceptual model. Hastings Center Report, 39(1), 30-39.

Appelbaum

P. S.

Lidz

C. W.

Klitzman

(2009b). Voluntariness of consent to research: A preliminary empirical investigation. IRB: A Review of Human Subjects Research, 31(6), 10-14.

Basic HHS Policy for Protection of Human Research Subjects. C.F.R. 45, §§ 46-46.101-46.124 (2017)

Bell

Salmon

(2011). What women who use drugs have to say about ethical research: Findings of an exploratory qualitative study. Journal of Empirical Research on Human Research Ethics, 6(4), 84-98.

Bonnie

R. J.

(2005). Judicially mandated treatment with naltrexone by opiate-addicted criminal offenders. Virginia Journal of Social Policy and the Law, 13, 64-88.

Cusack

K. J.

Steadman

H. J.

Herring

A. H.

(2010). Perceived coercion among jail diversion participants in a multisite study. Psychiatric Services, 61, 911-916.

10.

Dugosh

K. L.

Festinger

D. S.

Croft

J. R.

Marlowe

D. B.

(2010). Measuring coercion to participate in research within a doubly vulnerable population: Initial development of the Coercion Assessment Scale. Journal of Empirical Research on Human Research Ethics, 5, 93-102.

11.

Dugosh

K. L.

Festinger

D. S.

Lynch

K. G.

Marlowe

D. B.

(2014a). The survey of treatment entry pressures (STEP): Identifying client’s reasons for entering substance abuse treatment. Journal of Clinical Psychology, 70, 956-966.

12.

Dugosh

K. L.

Festinger

D. S.

Marlowe

D. B.

Clements

N. T.

(2014b). Developing an index to measure the voluntariness of consent to research. Journal of Empirical Research on Human Research Ethics, 9(4), 60-70.

13.

DuVal

Salmon

(2004). Research note: Ethics of drug treatment research with court-supervised subjects. Journal of Drug Issues, 34, 991-1006.

14.

Edens

J. F.

Epstein

Stiles

P. G.

Poythress

N. G.

(2011). Voluntary consent in correctional settings: Do offenders feel coerced to participate in research? Behavioral Sciences & the Law, 29, 771-795.

15.

Emanuel

E. J.

Wendler

Grady

(2000). What makes clinical research ethical? Journal of the American Medical Association, 283, 2701-2711.

16.

Festinger

D. S.

Dugosh

K. L.

Croft

J. R.

Arabia

P. L.

Marlowe

D. B.

(2011). Do research intermediaries reduce perceived coercion to enter research trials among criminally involved substance abusers? Ethics & Behavior, 21, 252-259.

17.

Friedmann

P. D.

Hoskinson

Jr. Gordon

Schwartz

Kinlock

Knight

. . . Frisman

L. K.

(2012). Medication-assisted treatment in criminal justice agencies affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, barriers, and intentions. Substance Abuse, 33(1), 9-18.

18.

Fry

Dwyer

(2001). For love or money? An exploratory study of why injecting drug users participate in research. Addiction, 96, 1319-1325.

19.

Gardner

Hoge

S. K.

Bennett

Roth

L. H.

Lidz

C. W.

Monahan

Mulvey

E. P.

(1993). Two scales for measuring patients’ perceptions for coercion during mental hospital admission. Behavioral Sciences & the Law, 11, 307-321.

20.

Gostin

L. O.

(2007). Biomedical research involving prisoners: Ethical values and legal regulation. Journal of the American Medical Association, 297, 737-740.

21.

Grabowski

O’Brien

C. P.

Mintz

(1979). Increasing the likelihood that consent is informed. Journal of Applied Behavior Analysis, 12, 283-284.

22.

Hanson

B. L.

Faulkner

S. A.

Brems

Corey

S. L.

Eldridge

G. D.

Johnson

M. E.

(2015). Key stakeholders’ perceptions of motivators for research participation among individuals who are incarcerated. Journal of Empirical Research on Human Research Ethics, 10, 360-367.

23.

Hawkins

J. S.

Emanuel

E. J.

(2005). Clarifying confusions about coercion. Hastings Center Report, 35(5), 16-19.

24.

Institute of Medicine. (2007). Ethical considerations for research involving prisoners. Washington, DC: The National Academies Press.

25.

Lee

J. D.

Friedmann

P. D.

Boney

T. Y.

Hoskinson

R. A.

McDonald

Gordon

. . . O’Brien

C. P.

(2015). Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: Rationale and design of a randomized controlled effectiveness trial. Contemporary Clinical Trials, 41, 110-117.

26.

Lee

J. D.

Friedmann

P. D.

Kinlock

T. W.

Nunes

E. V.

Boney

T. Y.

Hoskinson

R. A.

Jr. . . . O’Brien

C. P.

(2016). Extended-release naltrexone to prevent opioid relapse in criminal justice offenders. New England Journal of Medicine, 374, 1232-1242.

27.

Lidz

C. W.

Mulvey

E. P.

Hoge

S. K.

Kirsch

B. L.

Monahan

Bennett

N. S.

. . . Roth

L. H.

(1997). The validity of mental patients’ accounts of coercion-related behaviors in the hospital admission process. Law and Human Behavior, 21, 361-376.

28.

Marlowe

D. B.

Kirby

K. C.

Bonieskie

L. M.

Glass

D. J.

Dodds

L. D.

Husband

S. D.

. . . Festinger

D. S.

(1996). Assessment of coercive and noncoercive pressures to enter drug abuse treatment. Drug and Alcohol Dependence, 42, 77-84.

29.

McCann

S. K.

Campbell

M. K.

Entwistle

V. A.

(2010). Reasons for participating in randomised controlled trials: Conditional altruism and considerations for self. Trials, 11(1), Article 31.

30.

Moser

D. J.

Arndt

Kanz

J. E.

Benjamin

M. L.

Bayless

J. D.

Reese

R. L.

. . . Flaum

M. A.

(2004). Coercion and informed consent in research involving prisoners. Comprehensive Psychiatry, 45(1), 1-9.

31.

Polcin

D. L.

Beattie

(2007). Relationship and institutional pressure to enter treatment: Differences by demographics, problem severity, and motivation. Journal of Studies on Alcohol and Drugs, 68, 428-436.

32.

Protection of Human Subjects. C.F.R. 21, §§50-50.1-50.56 (2017).

33.

Rain

S. D.

Steadman

H. J.

Robbins

P. C.

(2003a). Perceived coercion and treatment adherence in an outpatient commitment program. Psychiatric Services, 54, 399-401.

34.

Rain

S. D.

Williams

V. F.

Robbins

P. C.

Monahan

Steadman

H. J.

Vesselinov

(2003b). Perceived coercion at hospital admission and adherence to mental health treatment after discharge. Psychiatric Services, 54, 103-105.

35.

Rash

C. J.

Stitzer

Weinstock

(2017). Contingency management: New directions and remaining challenges for an evidence-based intervention. Journal of Substance Abuse Treatment, 72, 10-18.

36.

Ross

(2010). What the medical excuse teaches us about the potential living donor as patient. American Journal of Transplantation, 10, 731-736.

37.

Steadman

H. J.

Gounis

Dennis

Hopper

Roche

Swartz

Robbins

P. C.

(2001). Assessing the New York City involuntary outpatient commitment pilot program. Psychiatric Services, 52, 330-336.

38.

Stiles

P. G.

Epstein

Poythress

Edens

J. F.

(2012). Protecting people who decline to participate in research: An example from a prison setting. IRB: A Review of Human Subjects Research, 34(2), 15-18.

39.

Sullivan

M. A.

Birkmayer

Boyarsky

B. K.

Frances

R. J.

Fromson

J. A.

Galanter

. . . Westermeyer

(2008). Uses of coercion in addiction treatment: Clinical aspects. The American Journal on Addictions, 17, 36-47.

40.

Thiessen

Kim

Y. A.

Formica

Bia

Kulkarni

(2015). Opting out: Confidentiality and availability of an “alibi” for potential living kidney donors in the USA. Journal of Medical Ethics, 41, 506-510. doi:10.1136/medethics-2014-102184

41.

Weisner

Hinman

Monahan

Bonnie

R. J.

Moore

C. D.

. . . Appelbaum

P. S.

(2009). Substance use, symptom, and employment outcomes of persons with a workplace mandate for chemical dependency treatment. Psychiatric Services, 60, 646-654.

42.

Wild

T. C.

Newton-Taylor

Alletto

(1998). Perceived coercion among clients entering substance abuse treatment: Structural and psychological determinants. Addictive Behaviors, 23, 81-95.